We may earn a commission when you click links to providers, and partner relationships can affect which providers we feature and their order. Advertiser Disclosure
Saxenda vs Wegovy: 6.4% vs 15.8% Weight Loss in STEP 8
Saxenda vs Wegovy: daily liraglutide vs weekly semaglutide. STEP 8: 6.4% vs 15.8% weight loss. Saxenda ends Jan 2027. Prices as of Oct 2026.
Chia Health
Our #1 pick for GLP-1 weight loss online
- One monthly price: clinician, medication and free shipping included
- Semaglutide or tirzepatide, as a weekly injection or a daily tablet
- No insurance needed; HSA/FSA and Klarna accepted
Compounded medications, not FDA-approved. Prices checked Nov 17, 2026. Advertiser Disclosure
$212.89 first month, then $349/mo
6-month plan: $249/mo, paid upfront ($1,396.89 for the first 6 months). Microdose: $109.19 first month, then $179/mo.
Head-to-head trial: STEP 8, JAMA 2022
In the STEP 8 head-to-head trial, weekly Wegovy users lost 15.8% of body weight at 68 weeks vs 6.4% on daily Saxenda. Saxenda is being discontinued, with last shipments in late January 2027.
We may earn a commission if you sign up through some links. Partner relationships can affect which providers we feature and their order; prices and medical facts are reported the same way for every provider.
| Measure | Saxenda (liraglutide 3 mg daily) | Wegovy (semaglutide 2.4 mg weekly) |
|---|---|---|
| Average weight loss | 6.4% | 15.8% |
| Lost 15% or more | 12.0% | 55.6% |
| Stopped for side effects | 12.6% | 3.2% |
| Shots per year | 365 | 52 |
”Novo Nordisk says it will discontinue Saxenda, with last shipments to wholesalers in late January 2027. The company says the decision is not the result of any safety or quality-related concerns.” Source: NovoCare Saxenda page, checked Oct 17, 2026.
01 At a glance
Saxenda vs Wegovy at a Glance
Both are Novo Nordisk GLP-1 drugs approved by the FDA for chronic weight management. The difference starts with the molecule: Saxenda is liraglutide, Wegovy is semaglutide. For the molecule-level view, see semaglutide vs liraglutide.
| Feature | Saxenda | Wegovy |
|---|---|---|
| Active ingredient | Liraglutide | Semaglutide |
| How often | 1 injection a day | Pen: 1 injection a week · Pill: 1 tablet a day |
| Target dose | 3 mg a day | Pen: 2.4 mg a week (HD: up to 7.2 mg) · Pill: 25 mg a day |
| Approved ages for weight | Adults; teens 12+ with body weight over 60 kg and obesity | Pen: adults and teens 12+ · Pill: adults only (not established in children) |
| Other approved uses | Weight management only | Lower risk of heart attack, stroke and CV death in adults with heart disease; MASH with liver fibrosis (pen) |
| Manufacturer self-pay price | None | Pen $199 for first 2 fills, then $349/mo; HD $399; pill $149 to $299 |
| Medicare GLP-1 Bridge ($50/mo) | Not included | Included, pen and pill |
| Generic | Yes, liraglutide (Hikma, Meitheal; Teva To Be Discontinued) | None |
| Status | Being discontinued, last shipments late Jan 2027 | Available |
Prices as of Oct 2026, from NovoCare and CMS. They can change.
02 Results
Wegovy vs Saxenda: Which Works Better in the STEP 8 Head-to-Head
STEP 8 is the only trial that put the two drugs side by side. It ran 68 weeks at 19 US sites with 338 adults with overweight or obesity and no diabetes, published in JAMA in 2022 (Rubino et al.). It was open-label, so people knew whether they were on the weekly or the daily drug.
- Wegovy (semaglutide 2.4 mg weekly)15.8%
- Saxenda (liraglutide 3 mg daily)6.4%
- Placebo (pooled)1.9%
For saxenda weight loss outside the head-to-head, the labels report their own trials. These used different people, lengths and designs, so do not line them up as a ranking:
- Saxenda label, Study 1: 7.4% average loss vs 3.0% on placebo at 56 weeks.
- Wegovy pen label, STEP 1: 14.9% vs 2.4% on placebo at 68 weeks.
- Wegovy pill label, 25 mg: 13.6% vs 2.4% on placebo at 64 weeks.
- Wegovy 7.2 mg label: 18.8% vs 15.5% on 2.4 mg at 72 weeks.
03 Dosing
Saxenda Dosing vs Wegovy Dosing: One Shot a Day vs One a Week
Saxenda is titrated weekly, Wegovy every 4 weeks (pen) or every 30 days (pill). That adds up to 365 injections a year on Saxenda vs 52 on the Wegovy pen. Your prescriber sets the dose.
Saxenda dosing schedule (label §2.2, Table 1)
| Week | Daily dose |
|---|---|
| 1 | 0.6 mg |
| 2 | 1.2 mg |
| 3 | 1.8 mg |
| 4 | 2.4 mg |
| 5 and on | 3 mg |
Wegovy dosing (label §2.2 to 2.3)
| Step | Pen, once weekly | Pill, once daily |
|---|---|---|
| Start | 0.25 mg, weeks 1 to 4 | 1.5 mg, days 1 to 30 |
| Escalation | 0.5 mg (wk 5 to 8), 1 mg (wk 9 to 12), 1.7 mg (wk 13 to 16) | 4 mg (days 31 to 60), 9 mg (days 61 to 90) |
| Maintenance | 2.4 mg from week 17 (or 1.7 mg); 7.2 mg optional after 4+ weeks on 2.4 mg | 25 mg from day 91 |
Label rules: for adults, 3 mg is the only maintenance dose, and Saxenda is stopped if 3 mg is not tolerated or if weight loss is under 4% at 16 weeks. Teens may drop to 2.4 mg, and stop if BMI has not fallen at least 1% after 12 weeks on maintenance. Missed a dose: take the next one as scheduled, no extra dose; after more than 3 days, restart at 0.6 mg.
Full step-by-step schedule: Wegovy dosage. Pill vs pen trade-offs: Wegovy pill vs injection.
04 Side effects
Saxenda Side Effects vs Wegovy Side Effects
Both drugs cause mostly stomach-related side effects, usually during dose increases. In STEP 8, gastrointestinal events were similar (84.1% on semaglutide, 82.7% on liraglutide), but fewer people stopped Wegovy because of side effects.
Saxenda (liraglutide)
- Nausea in adult trials: 39.3% vs 13.8% on placebo (label §6.1)
- STEP 8: 12.6% stopped for side effects
- Extra label warning: heart rate increase, with heart rate checked at regular intervals
Wegovy (semaglutide)
- Nausea in adult trials (2.4 mg): 44% vs 16% on placebo (label §6.1)
- STEP 8: 3.2% stopped for side effects
- Extra approved uses come with the same core warnings
Shared label warnings
In January 2026 the FDA asked for the suicidal-ideation warning to be removed from both labels after a review of 91 trials.
Tips for the queasy weeks: GLP-1 nausea guide. Semaglutide side effects in detail: Ozempic side effects.
05 Cost
Saxenda Cost vs Wegovy Cost in 2026
The biggest practical gap is price. Saxenda has no manufacturer self-pay program and its savings card closed to new enrollees on June 30, 2023. Wegovy has cash prices through NovoCare and a $50 Medicare option. Full breakdown of what Saxenda costs by pharmacy and plan: Saxenda cost.
| Option | Saxenda | Wegovy |
|---|---|---|
| Manufacturer self-pay | None | Pen: $199/mo for the first 2 fills (0.25 and 0.5 mg, new patients, through Dec 31, 2026), then $349/mo · HD 7.2 mg: $399/mo · Pill: $149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg) |
| With commercial insurance | Savings card closed to new enrollees (2023) | Savings card: as little as $25/mo, max savings $100/mo |
| Medicare GLP-1 Bridge | Not included | $50/mo copay, Jul 1, 2026 to Dec 31, 2027, eligibility rules apply |
| List price | Not published by Novo on NovoCare | $1,349.02 per pen box or pill bottle |
| From Jan 1, 2027 | Discontinued | Novo list price cut to $675/mo |
| Generic liraglutide | Teva has not published a price | No generic |
All prices as of Oct 2026 and subject to change. One 18 mg Saxenda or liraglutide pen lasts 6 days at 3 mg, so a 30-day supply at full dose is 5 pens; ask the pharmacy for its cash price on a 5-pen pack.
Go deeper: Wegovy cost, Medicare GLP-1 Bridge, Wegovy without insurance.
06 Generic
Is There a Generic Saxenda, and What Happens After January 2027?
Brand Saxenda leaving does not take liraglutide off the market. Generic liraglutide for weight management is FDA-approved and stays an option wherever a pharmacy stocks it, and asking “when will Saxenda be back in stock” no longer applies once brand shipments end.
Dec 23, 2014 · FDA approves Saxenda (liraglutide 3 mg) for chronic weight management.
Jun 30, 2023 · Saxenda savings card closes to new enrollees.
Aug 28, 2025 · Teva announces FDA approval and launch of generic Saxenda, which it calls the first generic GLP-1 indicated for weight loss. No price published.
Jan 13, 2026 · FDA requests removal of the suicidal-ideation warning from GLP-1 weight-loss labels, including Saxenda and Wegovy.
Late Jan 2027 · Last brand Saxenda shipments to wholesalers, per Novo Nordisk.
Compounded liraglutide is also sold online (for example by Henry Meds at $179/mo as of Oct 2026), but compounded drugs are not FDA-approved and are not the same as Saxenda or generic liraglutide.
07 Switching
Switching From Saxenda to Wegovy
Neither label gives a Saxenda-to-Wegovy dose conversion. Both labels say not to combine them with another GLP-1 drug.
- 01
Talk to your prescriber first. They decide when your last Saxenda dose is and when Wegovy starts.
- 02
Start Wegovy at the bottom. The label starts everyone at 0.25 mg weekly (pen) or 1.5 mg daily (pill), even after liraglutide.
- 03
Check coverage. A new drug often means a new prior authorization; without coverage, NovoCare self-pay is $199 for the first 2 fills.
- 04
Plan around the date. If you are still on Saxenda, set up the switch before shipments end in late January 2027.
How to get the prescription: how to get Wegovy.
08 Who picks Saxenda
Who Might Still Pick Saxenda or Generic Liraglutide?
Coverage only for liraglutide.
Some plans list liraglutide but not semaglutide. Generic liraglutide keeps that route open after brand Saxenda ends.
Teens 12 and older.
Saxenda and the Wegovy pen are both approved for teens with obesity; a clinician may prefer one based on history and tolerability.
Stopped semaglutide for side effects.
Liraglutide is a different molecule with a shorter action. Whether it is worth a try is a clinician decision.
Also comparing tirzepatide: Saxenda vs Zepbound and Zepbound vs Wegovy.
09 FAQ
FAQ
Which is better, Saxenda or Wegovy?
Is Saxenda being discontinued?
Is there a generic Saxenda?
Is Saxenda a GLP-1?
Can you switch from Saxenda to Wegovy?
Is Saxenda cheaper than Wegovy?
Is Saxenda the same as Ozempic?
More on Saxenda vs Ozempic and that pairing: Ozempic vs other GLP-1s.
Weekly instead of daily: check your Wegovy price
Sources
- Rubino DM et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022;327(2):138-150. Checked 2026-10-17.
- Novo Nordisk / FDA. Saxenda (liraglutide) injection, Prescribing Information, Revised 02/2026 (§1, §2.1 to 2.2, §5.5, §6.1, §14, §16). Checked 2026-10-17.
- Novo Nordisk / FDA. Wegovy (semaglutide) injection and tablets, Prescribing Information, Revised 06/2026 (§1, §2.2 to 2.3, §6.1, §8.4, §14). Checked 2026-10-17.
- NovoCare. Saxenda: discontinuation notice and savings status. Checked 2026-10-17.
- NovoCare. Wegovy self-pay and savings. Checked 2026-10-16.
- CMS. Medicare GLP-1 Bridge: information for Part D plans. Checked 2026-10-16.
- Teva. FDA approval and launch of generic Saxenda (liraglutide injection), Aug 28, 2025. Checked 2026-10-17.
- FDA Drug Safety Communication. Removal of suicidal behavior and ideation warning from GLP-1 weight-loss labels, Jan 13, 2026. Checked 2026-10-16. Saxenda first approval Dec 23, 2014: Drugs@FDA NDA 206321 approval package.
Last updated October 17, 2026 · By the GLP1-US Editorial Team
Chia Health: Chia Health sells compounded GLP-1 plans with medication included: semaglutide $212.89 the first month, then $349 a month, or $249 a month on a 6-month plan paid upfront. Not FDA-approved; no insurance needed.
Get StartedThis article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or qualified health provider with any questions about a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.
Ready to see if a GLP-1 is right for you?
Compare our top 5 providers and find the lowest price for your situation in under 5 minutes.
References
- FDA: Drug Approvals and Databases, U.S. Food & Drug Administration, 2024
- NIH: National Library of Medicine, PubMed, 2024
- Wegovy (semaglutide) Prescribing Information, Novo Nordisk, 2026
- Ozempic (semaglutide) Prescribing Information, Novo Nordisk, 2026